Biopharma Business

Tag "asthma"

GSK Reports Positive Results for Once-Daily Inhaled Corticosteroid

GlaxoSmithKline plc and Innoviva, Inc. announced positive headline results from a non-inferiority lung function study, which demonstrated that patients with well-controlled asthma were able to switch to the once-daily Relvar Ellipta (fluticasone furoate/vilanterol,

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here